What is the market doing?
What the tape says about MRNA
Moderna is +93% over the past year while the S&P 500 is +23%: 70 points ahead of the market.
+93%
1-year return · S&P 500 +23%
- vs 200-day average
- +212%
vs 200-day average · a clear uptrend
- RSI (14)
- 71
RSI (14) · overbought, bought harder than it has been sold
- Below its 52-week high
- −17%
Below its 52-week high
Details›
- Last close2026-08-26
- $62.96
- 1 monthS&P 500 +3.7%
- −7.7%
- 1 yearS&P 500 +23%
- +93%
- 5 yearsS&P 500 +87%
- −81%
- vs 50-day average$68.13
- +119%
- 52-week high
- $179.79
- 52-week low
- $22.36
- Annualised volatility
- 149%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$434K
| Year | Return |
|---|---|
| 2026 (year to date) | +405% |
| 2025 | −29% |
| 2024 | −58% |
| 2023 | −45% |
| 2022 | −29% |
| 2021 | +143% |
| 2020 | +434% |
| 2019 | +28% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 8 | 5 of 8 | +11% |
| Feb | 8 | 3 of 8 | +1.6% |
| Mar | 8 | 4 of 8 | +1.9% |
| Apr | 8 | 5 of 8 | +9.7% |
| May | 8 | 5 of 8 | +5.8% |
| Jun | 8 | 4 of 8 | +1.3% |
| Jul | 8 | 5 of 8 | +8.4% |
| Aug | 8 | 3 of 8 | +13% |
| Sep | 7 | 4 of 7 | −1.9% |
| Oct | 7 | 3 of 7 | −3.2% |
| Nov | 7 | 5 of 7 | +21% |
| Dec | 7 | 3 of 7 | −3.3% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Biotechnology
Ranks #30 of 145 by Smart Score